PETER SHIN: Open Payments
NPI 1689950438 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $884 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $354 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
Products named: AUSTEDO XR, COBENFY, REXULTI, Auvelity, NUPLAZID.
Industry payments across CA — which companies pay providers there.
